Kimberly J. Popovits

Director at Kiniksa Pharmaceuticals International · 8 reported transactions in 4 companies · latest report Jun 17, 2026

Their trades


KardiganKARD	Share award — · 20,706 shares	Jun 17, 2026
10x GenomicsTXG	Share award — · 8,829 shares	Jun 4, 2026
Kiniksa Pharmaceuticals InternationalKNSA	Exercised options $1.93M · 64,508 shares	Jul 30, 2025
Kiniksa Pharmaceuticals InternationalKNSA	Exercised options $290.2K · 18,760 shares	Jul 30, 2025
Kiniksa Pharmaceuticals InternationalKNSA	Exercised options $473.9K · 45,748 shares	Jul 30, 2025
Exact SciencesEXAS	Share award — · 9,994 shares	Jun 12, 2025
Kiniksa Pharmaceuticals InternationalKNSA	Exercised options — · 3,173 shares	Jun 5, 2025
10x GenomicsTXG	Share award — · 15,357 shares	Jun 3, 2025

Share awardKardigan

Jun 17, 2026 · KARD

20,706

Jun 4, 2026 · TXG

8,829

Jul 30, 2025 · KNSA

$1.93M

Jul 30, 2025 · KNSA

$290.2K

Jul 30, 2025 · KNSA

$473.9K

Jun 12, 2025 · EXAS

9,994

Jun 5, 2025 · KNSA

3,173

Jun 3, 2025 · TXG

15,357

8 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Director at Kiniksa Pharmaceuticals International · 8 reported transactions in 4 companies · latest report Jun 17, 2026


KardiganKARD	Share award — · 20,706 shares	Jun 17, 2026
10x GenomicsTXG	Share award — · 8,829 shares	Jun 4, 2026
Kiniksa Pharmaceuticals InternationalKNSA	Exercised options $1.93M · 64,508 shares	Jul 30, 2025
Kiniksa Pharmaceuticals InternationalKNSA	Exercised options $290.2K · 18,760 shares	Jul 30, 2025
Kiniksa Pharmaceuticals InternationalKNSA	Exercised options $473.9K · 45,748 shares	Jul 30, 2025
Exact SciencesEXAS	Share award — · 9,994 shares	Jun 12, 2025
Kiniksa Pharmaceuticals InternationalKNSA	Exercised options — · 3,173 shares	Jun 5, 2025
10x GenomicsTXG	Share award — · 15,357 shares	Jun 3, 2025